Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia-Reference-Cited by-同舟云学术

Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia

Published:2018-11 Issue: Volume:324 Page:76-80
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Fabis-Pedrini Marzena J.,Bundell Christine,Wee Chee-Keong,Lucas Michaela,McLean-Tooke Andrew,Mastaglia Frank L.,Carroll William M.,Kermode Allan G.

Funder

MSWA Post-Doctoral Research Fellowship

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference48 articles.

1. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: a cross sectional study;Apiwattanakul;Mult. Scler. Relat. Disord.,2014

2. Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients;Apiwattanakul;J. Neurol. Sci.,2012

3. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system;Argyriou;Acta Neurol. Scand.,2008

4. A population-based study of neuromyelitis optica in Caucasians;Asgari;Neurology,2011

5. Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study;Asgari;BMC Neurol.,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional first-line treatment failure rates in neuromyelitis optica spectrum disorder patients included in the Argentinean registry (RelevarEM);Multiple Sclerosis and Related Disorders;2024-09

2. Characterization of pain syndromes in patients with neuromyelitis optica;European Journal of Pain;2020-07-21

3. AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD;Frontiers in Neurology;2019-10-04